Literature DB >> 10191116

Tissue expression and subcellular localization of CLN3, the Batten disease protein.

L R Margraf1, R L Boriack, A A Routheut, I Cuppen, L Alhilali, C J Bennett, M J Bennett.   

Abstract

Juvenile neuronal ceroid lipofuscinosis (Batten disease) is a progressive neurologic disorder which results from mutations in the CLN3 gene, which normally produces a 48-kDa polypeptide of unknown function. To help characterize the CLN3 protein, we have studied its tissue distribution and subcellular localization in human tissues using three epitope-specific polyclonal antibodies to human CLN3 by immunoblot, immunocytochemical, and immunoelectron microscopic analysis. The most abundant CLN3 protein expression was in the gray matter of the brain, where it was localized to astrocytes, capillary endothelium, and neurons. CLN3 was also evident in peripheral nerve, in pancreatic islet cells, and within the seminiferous tubules in the testis. Staining was generally diffuse within the cytoplasm with some nuclear reactivity. Subcellular localization identified the CLN3 protein within the nucleus and along cell membranes. These results were contrasted with the cellular distribution of palmitoyl-protein thioesterase (PPT), the enzyme whose deficiency is responsible for infantile neuronal ceroid lipofuscinosis (CLN1). PPT was most abundant in brain and visceral macrophages where it displayed a coarse granular staining pattern typical of lysosomal distribution. Immunoelectron microscopy confirmed that PPT immunoreactivity was limited to lysosomes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191116     DOI: 10.1006/mgme.1999.2830

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.

Authors:  G de Voer; P van der Bent; A J G Rodrigues; G-J B van Ommen; D J M Peters; P E M Taschner
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.

Authors:  Luke A Wiley; Erin R Burnight; Arlene V Drack; Bailey B Banach; Dalyz Ochoa; Cathryn M Cranston; Robert A Madumba; Jade S East; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Gene Ther       Date:  2016-07-11       Impact factor: 5.695

3.  Screening for calcium channel modulators in CLN3 siRNA knock down SH-SY5Y neuroblastoma cells reveals a significant decrease of intracellular calcium levels by selected L-type calcium channel blockers.

Authors:  Kristina An Haack; Srinivas B Narayan; Haying Li; Ashley Warnock; Lu Tan; Michael J Bennett
Journal:  Biochim Biophys Acta       Date:  2010-10-07

4.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

5.  Identification of palmitoyl protein thioesterase 1 in human THP1 monocytes and macrophages and characterization of unique biochemical activities for this enzyme.

Authors:  Ran Wang; Abdolsamad Borazjani; Anberitha T Matthews; Lee C Mangum; Mariola J Edelmann; Matthew K Ross
Journal:  Biochemistry       Date:  2013-10-18       Impact factor: 3.162

6.  Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse.

Authors:  Shannon L Macauley; David F Wozniak; Catherine Kielar; Yun Tan; Jonathan D Cooper; Mark S Sands
Journal:  Exp Neurol       Date:  2009-02-10       Impact factor: 5.330

7.  CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells.

Authors:  Luis Tecedor; Colleen S Stein; Mark L Schultz; Hany Farwanah; Konrad Sandhoff; Beverly L Davidson
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

8.  Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.

Authors:  Xiao Zhang; Dan Zhang; Jennifer A Thompson; Shang-Chih Chen; Zhiqin Huang; Luke Jennings; Terri L McLaren; Tina M Lamey; John N De Roach; Fred K Chen; Samuel McLenachan
Journal:  Mol Genet Genomic Med       Date:  2021-01-26       Impact factor: 2.183

Review 9.  Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Authors:  Amanda L Getty; David A Pearce
Journal:  Cell Mol Life Sci       Date:  2010-08-01       Impact factor: 9.207

10.  Osmotic stress changes the expression and subcellular localization of the Batten disease protein CLN3.

Authors:  Amanda Getty; Attila D Kovács; Tímea Lengyel-Nelson; Andrew Cardillo; Caitlin Hof; Chun-Hung Chan; David A Pearce
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.